1. Pfizer to Raise Prices of its 41 Drugs in the US, in January 2019

Published: 19 Nov, 2018 | Tags: Pfizer, Raise, Prices, 41 Drugs, The US, January 2019, 2019, US, President, Trump  

1. Novartis’ Kisqali (ribociclib) (as a Combination Therapy) Receives CHMP’s Expanded Label Recommendation for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

Published: 19 Nov, 2018 | Tags:  Novartis, Kisqali, (ribociclib), (as a Combination Therapy) ,Receives, CHMP’s, Expanded Label, Recommendation , HR+/HER2-, Locally Advanced, Metastatic ,Breast Cancer

1. Gilead’s Vemlidy (Tenofovir Alafenamide) Receives NMPA (CFDA) Approval for Chronic Hepatitis B Virus (HBV) Infection

Published: 19 Nov, 2018 | Tags: Gilead, Vemlidy, (Tenofovir Alafenamide), Receives, NMPA, (CFDA), Approval, Chronic Hepatitis B Virus (HBV) Infection, FDA, Viread  

1. AstraZeneca Reports Results of Imfinzi (durvalumab) & Tremelimumab in Global P-III MYSTIC Trial for Stage IV Non-Small Cell Lung Cancer (NSCLC)

Published: 19 Nov, 2018 | Tags: AstraZeneca, Reports, Imfinzi, Tremelimumab, Global, P-III, Mystic Trial, NSCLC, mAb, Stage IV NSCLC, the US FDA, EU  

1. Genentech Collaborates with Immunocore to Co-develop IMC-C103C for MAGE-A4 (Melanoma-Associated Antigen A4)

Published: 20 Nov, 2018 | Tags: Genentech, Collaborates, Immunocore, Co-develop, IMC-C103C, MAGE-A4, Melanoma-Associated Antigen A4, Tecentriq  

1. Leidos Collaborates with GeoVax for the Development of Immunotherapies for Cancer

Published: 20 Nov, 2018 | Tags: Leidos, Collaborates, GeoVax, Development, Immunotherapies, Cancer, MVA-VLP vaccine platform, VLPs  

1. Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP, for Patients with Substance Use Disorder (SUD)

Published: 20 Nov, 2018 | Tags: Sandoz, Pear Therapeutics, Launches, reSET Medical Mobile APP, Substance Use Disorder (SUD), reSET Connect Patient Service Center  

1. Verily (Alphabet’s Division) Holds its Smart Lens Project

Published: 20 Nov, 2018 | Tags: Verily, Alphabet’s Division, Holds, Glucose-Detecting Contact Lens Project, Alcon  

1. Boston Scientific Acquires BTG with its Interventional Medicine Portfolio

Published: 21 Nov, 2018 | Tags: Boston Scientific, Acquires, BTG, Interventional Medicine Portfolio, TheraSphere Y-90 radiotherapy microspheres, the GALIL cryoablation system, EKOS Endovascular System    

1. OrthroXel’s Apex Femoral Nailing System Receives CE Mark Clearance in EU

Published: 21 Nov, 2018 | Tags OrthroXel, Apex Femoral Nailing System, Receives, CE Mark Clearance, EU    

1. Mylan Recalls 15 Batches of Valsartan Globally, for the Treatment of Hypertension

Published: 21 Nov, 2018 | Tags: Mylan, Recalls, Worldwide, Batches,Valsartan,  Blood Pressure Medicine, Amlodipine, Hydrochlorothiazide  

1. Leo Pharma Collaborates with PellePharm for the Development of Drug Candidate for Gorlin Syndrome and Basal Cell Carcinoma (BCC)

Published: 21 Nov, 2018 | Tags: Leo Pharma, Collaborates, Pelle Pharma, Develop, Commercialize, Patidegib, BCC, P-III trial, Q1’19  

1. Genentech’s Venclexta (venetoclax) Receives FDA’s Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML)

Published: 22 Nov, 2018 | Tags: Genentech, Venclexta (venetoclax), Receives, FDA’s, Accelerated Approval,Newly-Diagnosed Acute Myeloid Leukemia (AML), Decitabine, Azacitidine  

1. Pfizer and Zenith Epigenetics Collaborates to Evaluate ZEN-3694 & Talazoparib for TNBC

Published: 22 Nov, 2018 | Tags: Pfizer, Zenith Epigenetics, Collaborates, Evaluate, ZEN-3694, Talazoparib, TNBC, LA , Metastatic, TNBC    

1. Evotec and Immuneering Collaborates to Develop Novel Candidates for Rare Hereditary Metabolic Diseases

Published: 22 Nov, 2018 | Tags: Evotec, Immuneering, Collaborates , Develop ,Novel ,Candidates, Rare Hereditary Metabolic Diseases  

1. Medtronic to Acquire Nutrino Health Along with its AI-Based Continuous Glucose Monitoring (CGM) Technology

Published: 22 Nov, 2018 |Tags: Medtronic, Acquires, Nutrino Health, AI-Based Technology, Guardian Connect smart CGM system, Pro(TM)2 myLog app